Missouri 2025 Regular Session

Missouri Senate Bill SJR23 Compare Versions

Only one version of the bill is available at this time.

Old	New	Differences
1	1
2	2	FIRST REGULAR SESSION
3	3	SENATE JOINT RESOLUTION NO. 23
4	4	103RD GENERAL ASSEMBLY
5	5	INTRODUCED BY SENATOR SCHROER.
6	6	1204S.01I KRISTINA MARTIN, Secretary
7	7	JOINT RESOLUTION
8	8	Submitting to the qualified voters of Missouri, an amendment to article I of the Constitution of
9	9	Missouri, by adding thereto one new section relating to reproductive health care.
10	10
11	11	Be it resolved by the Senate, the House of Representatives concurring therein:
12	12	That at the next general election to be held in the 1
13	13	state of Missouri, on Tuesday next following the first Monday 2
14	14	in November, 2026, or at a special election to be called by 3
15	15	the governor for that purpose, there is he reby submitted to 4
16	16	the qualified voters of this state, for adoption or 5
17	17	rejection, the following amendment to article I of the 6
18	18	Constitution of the state of Missouri:7
19	19	Section A. Article I, Constitution of Missouri, is amended 1
20	20	by adding thereto one new section, to be known as section 36(a), 2
21	21	to read as follows:3
22	22	Section 36(a). 1. The provisions of this section 1
23	23	shall be known and may be cited as the "Reproductive Health 2
24	24	Care Protection Act". 3
25	25	2. Notwithstanding any provision of sectio n 36 of 4
26	26	article I of this Constitution to the contrary, the right to 5
27	27	reproductive freedom shall not be construed to include: 6
28	28	(1) The performance of gender transition surgeries or 7
29	29	the prescription or administration of cross -sex hormones or 8
30	30	puberty-blocking drugs for the purpose of gender transition; 9
31	31	and 10 SJR 23 2
32	32	(2) The payment for the performance or inducement, or 11
33	33	assistance with the performance or inducement, of abortions 12
34	34	by taxpayers, except in cases of medical emergencies. 13
35	35	3. Notwithstanding any provision of section 36 of 14
36	36	article I of this Constitution to the contrary, the right to 15
37	37	reproductive freedom shall not be construed to exempt any 16
38	38	person, firm, or corporation from civil liability for 17
39	39	medical malpractice, negligence, or wrongfu l death. 18
40	40	4. The general assembly shall have the authority to 19
41	41	enact laws to carry out the provisions of this section. 20
42	42	5. As used in this section, the following terms mean: 21
43	43	(1) "Cross-sex hormones", testosterone, estrogen, or 22
44	44	other androgens given to an individual in amounts that are 23
45	45	greater or more potent than would normally occur naturally 24
46	46	in a healthy individual of the same age and sex, but shall 25
47	47	not include hormones used to treat individuals born with a 26
48	48	medically-verifiable disorder of sex development or the 27
49	49	treatment of any infection, injury, disease, or disorder 28
50	50	unrelated to the purpose of gender transition; 29
51	51	(2) "Gender transition surgery", a surgical procedure 30
52	52	performed for the purpose of assisting an individual with 31
53	53	identifying with and living as a gender different from his 32
54	54	or her biological sex, but shall not include surgical 33
55	55	procedures for individuals born with a medically -verifiable 34
56	56	disorder of sex development or the treatment of any 35
57	57	infection, injury, disease, o r disorder unrelated to the 36
58	58	purpose of gender transition; 37
59	59	(3) "Medical emergency", a condition which, based on 38
60	60	reasonable medical judgment, so complicates the medical 39
61	61	condition of a pregnant woman as to necessitate the 40
62	62	immediate abortion of her p regnancy to avert the death of 41
63	63	the pregnant woman or for which a delay will create a 42 SJR 23 3
64	64	serious risk of substantial and irreversible physical 43
65	65	impairment of a major bodily function of the pregnant woman; 44
66	66	(4) "Puberty-blocking drugs", gonadotropin -releasing 45
67	67	hormone analogues or other synthetic drugs used to stop 46
68	68	luteinizing hormone secretion and follicle stimulating 47
69	69	hormone secretion, synthetic antiandrogen drugs to block the 48
70	70	androgen receptor, or any other drug used to delay or 49
71	71	suppress pubertal development in children for the purpose of 50
72	72	assisting an individual with a gender transition, but shall 51
73	73	not include drugs used to treat individuals born with a 52
74	74	medically-verifiable disorder of sex development or the 53
75	75	treatment of any infection, injury, di sease, or disorder 54
76	76	unrelated to the purpose of gender transition. 55
77	77	